Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Knock your SOCS off!
Derek LeRoith, Peter Nissley
Derek LeRoith, Peter Nissley
Published February 1, 2005
Citation Information: J Clin Invest. 2005;115(2):233-236. https://doi.org/10.1172/JCI24228.
View: Text | PDF
Commentary

Knock your SOCS off!

  • Text
  • PDF
Abstract

The growth hormone/IGF-1–signaling (GH/IGF-1–signaling) system is involved in numerous physiological processes during normal growth and development and also in the aging process. Understanding the regulation of this system is therefore of importance to the biologist. Studies conducted over the past decade have shown that the JAK/STAT pathways are involved in GH signaling to the nucleus. More recently, evidence has been presented that a member of the SOCS family, SOCS2, is a negative regulator of GH signaling. This story began several years ago with the dramatic demonstration of gigantism in the SOCS2-knockout mouse. A more specific definition of the role of SOCS2 in GH signaling is provided in this issue of the JCI by the demonstration that the overgrowth phenotype of the SOCS2–/– mouse is dependent upon the presence of endogenous GH and that administration of GH to mice lacking both endogenous GH and SOCS2 produced excessive growth.

Authors

Derek LeRoith, Peter Nissley

×

Total citations by year

Year: 2024 2023 2022 2021 2018 2016 2015 2014 2013 2011 2008 2007 2006 Total
Citations: 1 1 1 2 1 1 1 2 1 1 3 1 2 18
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (18)

Title and authors Publication Year
Unravelling the druggability and immunological roles of the SOCS-family proteins
Lynch DM, Forrester B, Webb T, Ciulli A
Frontiers in Immunology 2024
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
Zeng Z, Fu M, Hu Y, Wei Y, Wei X, Luo M
Molecular Cancer 2023
Identification of growth hormone receptor as a relevant target for precision medicine in low‐EGFR expressing glioblastoma
Verreault M, Segoviano Vilchis I, Rosenberg S, Lemaire N, Schmitt C, Guehennec J, Royer\u2010Perron L, Thomas J, Lam TT, Dingli F, Loew D, Ducray F, Paris S, Carpentier C, Marie Y, Laigle\u2010Donadey F, Rousseau A, Pigat N, Boutillon F, Bielle F, Mokhtari K, Frank SJ, de Reyniès A, Hoang\u2010Xuan K, Sanson M, Goffin V, Idbaih A
Clinical and Translational Medicine 2022
Unraveling the molecular mechanisms of hyperlipidemia using integrated lncRNA and mRNA microarray data
Xu B, Wang N, Xu X, Cai Y
Experimental and therapeutic medicine 2021
Early expression of requisite developmental growth hormone imprinted cytochromes P450 and dependent transcription factors
Banerjee S, Hayes AM, Shapiro BH
Endocrine Connections 2021
Post-Receptor Inhibitors of the GHR-JAK2-STAT Pathway in the Growth Hormone Signal Transduction
M Wójcik, A Krawczyńska, H Antushevich, A Herman
International journal of molecular sciences 2018
Growth Hormone – A Newly Identified Developmental Organizer
Das RK, Banerjee S, Shapiro BH
The Journal of endocrinology 2016
Permanent Uncoupling of Male-specific CYP2C11 Transcription / Translation by Perinatal Glutamate
Banerjee S, Das RK, Giffear KA, Shapiro BH
Toxicology and Applied Pharmacology 2015
Regulation and function of signal transducer and activator of transcription 3
QR Qi, ZM Yang
World journal of biological chemistry 2014
Irreversible perinatal imprinting of adult expression of the principal sex-dependent drug-metabolizing enzyme CYP2C11
Das RK, Banerjee S, Shapiro BH
The FASEB Journal 2014
Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression and Survival in Operable Squamous-Cell Laryngeal Cancer
Mountzios G, Kostopoulos I, Kotoula V, Sfakianaki I, Fountzilas E, Markou K, Karasmanis I, Leva S, Angouridakis N, Vlachtsis K, Nikolaou A, Konstantinidis I, Fountzilas G
PloS one 2013
Time series gene expression profiling and temporal regulatory pathway analysis of BMP6 induced osteoblast differentiation and mineralization
Luo W, Friedman MS, Hankenson KD, Woolf PJ
BMC Systems Biology 2011
Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21
T Inagaki, VY Lin, R Goetz, M Mohammadi, DJ Mangelsdorf, SA Kliewer
Cell Metabolism 2008
SARCOPENIA: ITS ASSESSMENT, ETIOLOGY, PATHOGENESIS, CONSEQUENCES AND FUTURE PERSPECTIVES
ROLLAND Y, CZERWINSKI S, VAN KAN GA, MORLEY JE, CESARI M, ONDER G, WOO J, BAUMGARTNER R, PILLARD F, BOIRIE Y, CHUMLEA WM, VELLAS B
The journal of nutrition, health & aging 2008
Neuroinflammation and Microglia: Considerations and approaches for neurotoxicity assessment
Harry GJ, Kraft AD
Expert Opinion on Drug Metabolism & Toxicology 2008
Regulation of the gonadal transcriptome during sex determination and testis morphogenesis: comparative candidate genes
Clement TM, Anway MD, Uzumcu M, Skinner\u2019 MK
Reproduction (Cambridge, England) 2007
Regulation of inducible nitric oxide synthase gene in glial cells
RN Saha, K Pahan
Antioxidants & Redox Signaling 2006
Signals for the induction of nitric oxide synthase in astrocytes
RN Saha, K Pahan
Neurochemistry International 2006

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts